<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="3.0" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS Pathog</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plospath</journal-id><journal-title-group>
<journal-title>PLoS Pathogens</journal-title></journal-title-group>
<issn pub-type="ppub">1553-7366</issn>
<issn pub-type="epub">1553-7374</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, USA</publisher-loc></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">PPATHOGENS-D-13-02172</article-id>
<article-id pub-id-type="doi">10.1371/journal.ppat.1003871</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Pearls</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biology</subject><subj-group><subject>Microbiology</subject></subj-group></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine</subject><subj-group><subject>Infectious diseases</subject><subj-group><subject>Bacterial diseases</subject><subj-group><subject>Bloodstream infections</subject><subject>Staphylococcus aureus</subject></subj-group></subj-group></subj-group></subj-group></article-categories>
<title-group>
<article-title>Igniting the Fire: <italic>Staphylococcus aureus</italic> Virulence Factors in the Pathogenesis of Sepsis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Powers</surname><given-names>Michael E.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Wardenburg</surname><given-names>Juliane Bubeck</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib>
</contrib-group>
<aff id="aff1"><label>1</label><addr-line>Department of Microbiology, The University of Chicago, Chicago, Illinois, United States of America</addr-line></aff>
<aff id="aff2"><label>2</label><addr-line>Department of Pediatrics, The University of Chicago, Chicago, Illinois, United States of America</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple"><name name-style="western"><surname>Heitman</surname><given-names>Joseph</given-names></name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/></contrib>
</contrib-group>
<aff id="edit1"><addr-line>Duke University Medical Center, United States of America</addr-line></aff>
<author-notes>
<corresp id="cor1">* E-mail: <email xlink:type="simple">jbubeckw@peds.bsd.uchicago.edu</email></corresp>
<fn fn-type="conflict"><p>I have read the journal's policy and have the following conflicts: JBW has the potential to receive royalties from Novartis Vaccines and Diagnostics in relation to patents owned by the University of Chicago. This does not alter our adherence to all PLOS policies on sharing data and materials.</p></fn>
</author-notes>
<pub-date pub-type="collection"><month>2</month><year>2014</year></pub-date>
<pub-date pub-type="epub"><day>13</day><month>2</month><year>2014</year></pub-date>
<volume>10</volume>
<issue>2</issue>
<elocation-id>e1003871</elocation-id><permissions>
<copyright-year>2014</copyright-year>
<copyright-holder>Powers, Bubeck Wardenburg</copyright-holder><license xlink:type="simple"><license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><funding-group><funding-statement>This work was supported by NIH award AI097434-01 to JBW. The authors also acknowledge membership in and support from the Region V “Great Lakes” RCE (NIH award 2-U54-AI-057153). MEP was partially supported by NIH Grant T32 GM007183 and American Heart Association pre-doctoral fellowship 13PRE14560065. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><page-count count="4"/></counts></article-meta>
</front>
<body><sec id="s1">
<title/>
<p>Sepsis is a devastating disease process characterized by a systemic inflammatory response in the host, evoked by a known or suspected pathogen. <italic>Staphylococcus aureus</italic> has emerged as a leading etiologic agent of sepsis, owing to its propensity to cause deep-seated tissue infection and bacteremia <xref ref-type="bibr" rid="ppat.1003871-Lowy1">[1]</xref>. <italic>S. aureus</italic> harbors an arsenal of virulence factors to facilitate tissue adhesion, immune evasion, and host cell injury. In the bloodstream, these factors cause inflammation, impair immune cell function, alter coagulation, and compromise vascular integrity. This review will discuss key secreted and surface-anchored proteins required for <italic>S. aureus</italic> infection in the hostile host environment of the bloodstream, emphasizing mechanistic insights on virulence factor function that illustrate the complex nature of the host–pathogen interaction. While we currently lack a clear understanding of the temporal and spatial integration of these virulence factors in the bloodstream, it is apparent that <italic>S. aureus</italic> triggers pathophysiologic disturbances that are further amplified by the host inflammatory response, culminating in the severe clinical manifestations of sepsis and septic shock.</p>
</sec><sec id="s2">
<title>Inflammation: An Early <italic>S. aureus</italic> Insult in Sepsis</title>
<p>The clinical manifestations of sepsis span a continuum of severity, in the most extreme form termed “septic shock,” in which vascular insults and systemic inflammation lead to compromised cardiac function and blood pressure, culminating in impaired oxygen delivery to the tissues and organ failure. In the United States, ∼750,000 individuals suffer from sepsis per year, with mortality rates that approach or even exceed 50% in severe disease <xref ref-type="bibr" rid="ppat.1003871-Angus1">[2]</xref>. Multiple clinical trials aimed at curbing the host inflammatory response to severe infection have yielded limited clinical success <xref ref-type="bibr" rid="ppat.1003871-Russell1">[3]</xref>. The mainstay of therapy for sepsis and septic shock remains 2-fold: (1) rapid treatment of the underlying infection and (2) early resuscitation to blunt physiologic abnormalities that potentiate disease progression <xref ref-type="bibr" rid="ppat.1003871-Cannon1">[4]</xref>. The nature of these beneficial interventions focuses attention on rigorously defining the inciting insult caused by the pathogen.</p>
<p>Multiple <italic>S. aureus</italic> proteins and cell wall components are pro-inflammatory, eliciting host responses similar to gram-negative lipopolysaccharide (LPS) <xref ref-type="bibr" rid="ppat.1003871-Salomao1">[5]</xref>. The production of cytokines, including TNF-α and IL-6, results from the action of <italic>S. aureus</italic> lipoproteins on mononuclear phagocytes through TLR-2 pathway activation <xref ref-type="bibr" rid="ppat.1003871-Hashimoto1">[6]</xref>, <xref ref-type="bibr" rid="ppat.1003871-BubeckWardenburg1">[7]</xref>. Furthermore, bloodstream exposure of rat hosts to peptidoglycan and lipoteichoic acid leads to induction of IL-1 and IFN-γ <xref ref-type="bibr" rid="ppat.1003871-DeKimpe1">[8]</xref>. Toxin-induced cellular injury also elicits prominent host inflammatory responses. In the bloodstream, circulating immune cells and the vascular endothelium are primary targets of staphylococcal virulence factors. Among the longest studied of these toxins are the staphylococcal superantigens that potently stimulate non-specific T-cell proliferation and activation and potentiate the host inflammatory response associated with sepsis <xref ref-type="bibr" rid="ppat.1003871-SalgadoPabon1">[9]</xref>. A family of bi-component leukotoxins including Panton-Valentine Leukocidin (PVL), Leukocidin AB/GH (LukAB/GH), Leukocidin ED (LukED), and γ-hemolysin (Hlg) injure an array of leukocytes including neutrophils, mononuclear phagocytes, and T cells <xref ref-type="bibr" rid="ppat.1003871-Yoong1">[10]</xref>. Also contributing to leukocyte injury is the family of cytolytic peptides termed phenol soluble modulins (PSMs) <xref ref-type="bibr" rid="ppat.1003871-Wang1">[11]</xref> and the small pore-forming toxin α-hemolysin (α-toxin, Hla) (<xref ref-type="fig" rid="ppat-1003871-g001">Figure 1a</xref>) <xref ref-type="bibr" rid="ppat.1003871-Berube1">[12]</xref>. Genetic regulatory control that leads to increased production of PVL, PSMs, and α-toxin in highly virulent methicillin-resistant <italic>S. aureus</italic> (MRSA) strains has been described as a molecular mechanism that underlies increased disease severity observed upon infection with these isolates <xref ref-type="bibr" rid="ppat.1003871-Li1">[13]</xref>–<xref ref-type="bibr" rid="ppat.1003871-DeLeo1">[15]</xref>. These virulence factors are potent stimulants of leukocyte inflammatory responses <xref ref-type="bibr" rid="ppat.1003871-Yoong1">[10]</xref>, <xref ref-type="bibr" rid="ppat.1003871-Berube1">[12]</xref>, <xref ref-type="bibr" rid="ppat.1003871-Malachowa1">[16]</xref>. <italic>S. aureus</italic> mutants engineered to lack expression of even one of these toxins exhibit virulence defects in experimental infection <xref ref-type="bibr" rid="ppat.1003871-Wang1">[11]</xref>, <xref ref-type="bibr" rid="ppat.1003871-Powers1">[17]</xref>–<xref ref-type="bibr" rid="ppat.1003871-Dumont1">[19]</xref>, suggesting that the collective impact of this group of toxins on inflammation and destabilization of the host during bloodstream infection is substantial.</p>
<fig id="ppat-1003871-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.ppat.1003871.g001</object-id><label>Figure 1</label><caption>
<title>Overview of <italic>S. aureus</italic> virulence factors that contribute to the pathogenesis of sepsis.</title>
<p>(a) Leukocytes are targeted and injured by bi-component leukocidins (PVL, LukAB/GH, LukED, and Hlg, blue and orange), phenol-soluble modulins (PSM, purple), and α-toxin (Hla, green). (b) Inhibition of host complement pathways occurs through Chemotaxis Inhibitory Protein of Staphylococci (CHIPS) binding to the C5a receptor and (c) Staphylococcal Complement Inhibitor (SCIN)-mediated blockade of C3 convertase activity. (d) Staphylococcal protein A (SpA) binds to host antibodies, preventing opsonophagocytosis and contributing to apoptotic death of B cells. (e) Coagulase (Coa) and von Willebrand factor binding protein (vWbp) initiate fibrin clot formation, facilitating the formation of staphylococcal aggregates in the blood through the action of clumping factors A and B (ClfA/B). (f) Platelet traps surround staphylococci that adhere to macrophage-like Kupffer cells in the liver sinusoid. (g) Fibronectin-binding proteins A and B (FnBPA/B) bind to integrin α5β1, enabling the tethering of <italic>S. aureus</italic> to endothelial cells in the context of blood flow. (h) Expression of <italic>S. aureus</italic> α-toxin (Hla) causes direct injury to the endothelium, disrupting the integrity of the endothelial barrier.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.ppat.1003871.g001" position="float" xlink:type="simple"/></fig></sec><sec id="s3">
<title>Escape from Innate Immune Cells: A Key to Bloodstream Survival</title>
<p>In concert with direct leukocyte injury, <italic>S. aureus</italic> utilizes a number of strategies to modulate the innate host immune response and prevent bacterial clearance in the bloodstream <xref ref-type="bibr" rid="ppat.1003871-Nizet1">[20]</xref>. Most clinical <italic>S. aureus</italic> isolates express a polysaccharide capsule that affords protection against phagocyte-mediated clearance; furthermore, the pathogen is able to resist killing in the phagocyte. <italic>S. aureus</italic> also secretes factors that function to dampen leukocyte recruitment or prevent opsonophagocytic uptake as a predecessor to intracellular killing. Two of the best-studied of these proteins are <underline>CH</underline>emotaxis <underline>I</underline>nhibitory <underline>P</underline>rotein of <underline>S</underline>taphylococci (CHIPS) and <underline>S</underline>taphylococcal <underline>C</underline>omplement <underline>IN</underline>hibitor (SCIN). CHIPS binds to the cellular receptors for C5a and N-formyl peptides, diminishing the ability of both bacterial peptides and complement activation to function as leukocyte chemoattractants (<xref ref-type="fig" rid="ppat-1003871-g001">Figure 1b</xref>) <xref ref-type="bibr" rid="ppat.1003871-deHaas1">[21]</xref>, <xref ref-type="bibr" rid="ppat.1003871-Postma1">[22]</xref>. SCIN potently inhibits human complement pathway defenses by blocking C3 convertase activity, reducing the deposition of the C3b opsonin on <italic>S. aureus</italic> and decreasing neutrophil uptake and killing <xref ref-type="bibr" rid="ppat.1003871-Rooijakkers1">[23]</xref> (<xref ref-type="fig" rid="ppat-1003871-g001">Figure 1c</xref>). Both of these staphylococcal virulence factors display human specificity and are secreted during early bacterial growth to provide rapid evasion of innate immunity <xref ref-type="bibr" rid="ppat.1003871-Rooijakkers2">[24]</xref>.</p>
<p>To limit the function of innate immune cells that successfully circumvent anti-chemotactic signals, <italic>S. aureus</italic> utilizes the cell-wall–anchored Staphylococcal protein A (SpA) to preclude antibody-driven opsonophagocytic clearance. SpA binds to the F<sub>c</sub> and F<sub>ab</sub> regions of host antibodies <xref ref-type="bibr" rid="ppat.1003871-Lindmark1">[25]</xref>, preventing staphylococcal antigen recognition and F<sub>c</sub>-mediated effector functions. SpA also engages the B cell receptor and initiates activation-induced apoptotic death of V<sub>H</sub>3<sup>+</sup> B cells (<xref ref-type="fig" rid="ppat-1003871-g001">Figure 1d</xref>) <xref ref-type="bibr" rid="ppat.1003871-Goodyear1">[26]</xref>. <italic>S. aureus</italic> SpA mutants display virulence defects in an intraperitoneal model of lethal infection as well as intravenous infection that leads to arthritis and renal abscess formation <xref ref-type="bibr" rid="ppat.1003871-Cheng1">[27]</xref>–<xref ref-type="bibr" rid="ppat.1003871-Palmqvist1">[29]</xref>. Immunization with an inactive, “non-toxinogenic” SpA variant is protective in lethal <italic>S. aureus</italic> sepsis, promoting opsonophagocytic clearance in the blood <xref ref-type="bibr" rid="ppat.1003871-Kim1">[28]</xref>. In addition to these immunoevasion strategies and the broadly toxic effects of the array of staphylococcal toxins on host immune cells <xref ref-type="bibr" rid="ppat.1003871-Yoong1">[10]</xref>–<xref ref-type="bibr" rid="ppat.1003871-Berube1">[12]</xref>, recent studies indicate a prominent role for LukED in bloodstream infection by virtue of its ability to injure monocytes and lymphocytes, diminishing phagocytic uptake and promoting pathogen dissemination <xref ref-type="bibr" rid="ppat.1003871-Alonzo1">[18]</xref>, <xref ref-type="bibr" rid="ppat.1003871-ReyesRobles1">[30]</xref>. Collectively, these bacterial defense mechanisms increase the burden of staphylococci in the blood, further compromising the septic host.</p>
</sec><sec id="s4">
<title>Modulation of Intravascular Coagulation: A Host–Pathogen Tug-of-War</title>
<p>Coagulopathy is another hallmark of septic shock, manifest as pathologic clotting within the microvasculature and a predisposition toward systemic bleeding <xref ref-type="bibr" rid="ppat.1003871-Russell1">[3]</xref>. <italic>S. aureus</italic> encodes virulence factors that modulate both soluble and cell-mediated pathways of coagulation. Physiologic coagulation in response to injury requires the rapid, localized activation of platelets, together with activation of the soluble clotting cascade. This serine protease-based cascade culminates in the enzymatic conversion of prothrombin to thrombin, in turn promoting the cleavage of fibrinogen to soluble fibrin monomers that polymerize into insoluble fibrin. Platelet-fibrin matrices form a physical substrate for plugging of the injured vasculature. While these processes are tightly regulated to ensure hemostasis yet avoid untoward intravascular thrombosis, bacterial virulence factors and the underlying host inflammatory state in sepsis induce pathologic alterations of coagulation. The staphylococcal virulence factors coagulase (Coa) and von Willebrand factor binding protein (vWbp) promote the non-catalytic activation of prothrombin, yielding cleavage of soluble fibrinogen to engender fibrin clot formation in the absence of an inciting injury <xref ref-type="bibr" rid="ppat.1003871-Panizzi1">[31]</xref>, <xref ref-type="bibr" rid="ppat.1003871-Bjerketorp1">[32]</xref>. Fibrin clots promote clumping factor protein-mediated (ClfA and ClfB) aggregation of staphylococci (<xref ref-type="fig" rid="ppat-1003871-g001">Figure 1e</xref>) <xref ref-type="bibr" rid="ppat.1003871-Cheng1">[27]</xref>. Agglutination of <italic>S. aureus</italic> in the blood promotes bacterial survival, noted by the significant virulence defect in <italic>S. aureus</italic> strains that lack expression of Coa, vWbp, and ClfA <xref ref-type="bibr" rid="ppat.1003871-McAdow1">[33]</xref>. In this context, survival is favored by protection of the aggregated organisms against phagocytic clearance. As activation of host coagulation pathways is proinflammatory <xref ref-type="bibr" rid="ppat.1003871-Schouten1">[34]</xref>, manipulation of this pathway by <italic>S. aureus</italic> likely contributes to the systemic inflammatory response.</p>
<p>Recent observations indicate the importance of thrombosis in immunodefense <xref ref-type="bibr" rid="ppat.1003871-Engelmann1">[35]</xref>, demonstrating that platelets confer anti-staphylococcal immunity to bloodstream infection <xref ref-type="bibr" rid="ppat.1003871-Wong1">[36]</xref>. Intravital imaging revealed that platelets form aggregates around staphylococci adhered to macrophage-like Kupffer cells associated with the liver sinusoidal endothelium, entrapping <italic>S. aureus</italic> and facilitating pathogen clearance (<xref ref-type="fig" rid="ppat-1003871-g001">Figure 1f</xref>) <xref ref-type="bibr" rid="ppat.1003871-Wong1">[36]</xref>. Suggesting the host-protective role of these traps, experimental platelet depletion leads to increased mortality from bloodstream infection <xref ref-type="bibr" rid="ppat.1003871-Wong1">[36]</xref>. While the role of platelets as innate immune cells has recently gained considerable attention, the modulation of normal platelet function by <italic>S. aureus</italic> has long been suggested by the ability of α-toxin to initiate platelet activation and aggregation <xref ref-type="bibr" rid="ppat.1003871-Bhakdi1">[37]</xref>. α-toxin–induced platelet activation would thereby seem to promote the formation of platelet traps and support bacterial clearance—a paradoxical “anti-virulence” effect, highlighting the need to further investigate the precise molecular mechanisms by which staphylococcal virulence factors modulate platelet function in innate immunity.</p>
</sec><sec id="s5">
<title>The Microvascular Endothelium: A Site of Coordination?</title>
<p>Blood flow presents a major hurdle to both the pathogen and the host during intravascular infection. The ability of immune cells to identify and then contain <italic>S. aureus</italic> in the context of a branching vascular tree and the dilutional effects of blood flow is challenged. Conversely, the pathogen is challenged to (1) constrain the delivery of soluble virulence factors that initiate pathologic coagulation in flowing blood and (2) overcome fluid shear stress to adhere to the vascular wall and promote dissemination. Fibronectin-binding protein A (FnBPA) is a surface-displayed protein that facilitates endothelial adherence (<xref ref-type="fig" rid="ppat-1003871-g001">Figure 1g</xref>) <xref ref-type="bibr" rid="ppat.1003871-Edwards1">[38]</xref>. Variations in FnBPA underlie differences in fibronectin-binding affinity; high-affinity variants enhance endothelial cell binding and correlate with increased endothelial invasion in bloodstream infection <xref ref-type="bibr" rid="ppat.1003871-Edwards1">[38]</xref>. The initial tethering of <italic>S. aureus</italic> to the endothelium may favor the establishment of a microenvironment in the small vessels or slow-flow vessels, such as liver sinusoids, in which <italic>S. aureus</italic>–induced coagulation and aggregate formation enhances the localized elaboration of virulence factors (<xref ref-type="fig" rid="ppat-1003871-g001">Figure 1h</xref>) <xref ref-type="bibr" rid="ppat.1003871-Carnes1">[39]</xref>.</p>
<p>A primary molecular mechanism for bacterial-induced vascular permeability is endothelial disruption due to extreme inflammation <xref ref-type="bibr" rid="ppat.1003871-Schouten1">[34]</xref>. In addition to its role in leukocyte and platelet injury, recent studies suggest that α-toxin co-opts the function of its cellular receptor <underline>A D</underline>isintegrin <underline>a</underline>nd <underline>M</underline>etalloprotease 10 (ADAM10) to disrupt the endothelial barrier by promoting the untimely cleavage of vascular endothelial (VE)-cadherin, destroying the inter-cellular junction that is required for vascular integrity <xref ref-type="bibr" rid="ppat.1003871-Powers1">[17]</xref>. As an intact endothelium forms the principal physical barrier to intravascular dissemination of bacterial pathogens, disruption of this barrier is expected to promote dissemination, a common and severe consequence of <italic>S. aureus</italic> sepsis. Damaged endothelium is also a potent stimulus for the rapid recruitment of platelets and activation of soluble clotting cascades. The microvascular endothelial surface may, thus, form a site wherein the pathogen, its armamentarium of virulence factors, platelets, leukocytes, and host coagulation proteins are co-localized. This “coordination” site may simultaneously trigger microvascular occlusion and increased vascular permeability—events that decrease effective blood flow to the tissues and precipitate sepsis-associated vital organ failure.</p>
</sec><sec id="s6">
<title>Towards the Future: Insights That May Change <italic>S. aureus</italic> Sepsis</title>
<p>The devastating mortality of sepsis and the inability of current clinical approaches to mitigate disease testify to our limited understanding of the complex host–pathogen interaction in the bloodstream. While the virulence factors discussed herein each contributes to sepsis pathogenesis, loss of any one factor is insufficient for complete protection against experimental <italic>S. aureus</italic> challenge. Similarly, vaccine approaches that target isolated virulence factors do not provide complete protection against lethal sepsis <xref ref-type="bibr" rid="ppat.1003871-Bagnoli1">[40]</xref>. Together, these observations highlight our need to understand the temporospatial regulation of virulence factor expression and action in vivo. While exaggerated host inflammatory responses are associated with the progression of severe septic shock, insults directly delivered by <italic>S. aureus</italic>—coagulopathy, immune cell injury, microvascular occlusion, and barrier damage—collectively mirror disease endpoints in sepsis. These insults likely initiate the very pathophysiologic state that is then exacerbated by an untoward host response. While multiple blood-borne bacteria incite endothelial injury and lead to a coagulopathic state manifested as sepsis <xref ref-type="bibr" rid="ppat.1003871-Lemichez1">[41]</xref>, whether a deliberate pathogen-driven coordination of these events occurs to promote virulence requires further study. The host–pathogen interaction in the bloodstream has proven extremely challenging to redirect in favor of the host, in spite of the commonality of these observed physiologic disturbances. The essential role of bacterial virulence factors as catalysts of sepsis, however, suggests that a keen focus on understanding how these factors are integrated in time and space within the vasculature should yield new insights for sepsis prevention and therapy in the coming years.</p>
</sec></body>
<back>
<ack>
<p>We thank Nathania Hau for compilation of the figure depicting <italic>S. aureus</italic> virulence factors in the bloodstream.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="ppat.1003871-Lowy1"><label>1</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lowy</surname><given-names>FD</given-names></name> (<year>1998</year>) <article-title><italic>Staphylococcus aureus</italic> infections</article-title>. <source>N Engl J Med</source> <volume>339</volume>: <fpage>520</fpage>–<lpage>532</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1003871-Angus1"><label>2</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Angus</surname><given-names>DC</given-names></name>, <name name-style="western"><surname>Linde-Zwirble</surname><given-names>WT</given-names></name>, <name name-style="western"><surname>Lidicker</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Clermont</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Carcillo</surname><given-names>J</given-names></name>, <etal>et al</etal>. (<year>2001</year>) <article-title>Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care</article-title>. <source>Crit Care Med</source> <volume>29</volume>: <fpage>1303</fpage>–<lpage>1310</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1003871-Russell1"><label>3</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Russell</surname><given-names>JA</given-names></name> (<year>2006</year>) <article-title>Management of sepsis</article-title>. <source>N Engl J Med</source> <volume>355</volume>: <fpage>1699</fpage>–<lpage>1713</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1003871-Cannon1"><label>4</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cannon</surname><given-names>CM</given-names></name>, <name name-style="western"><surname>Holthaus</surname><given-names>CV</given-names></name>, <name name-style="western"><surname>Zubrow</surname><given-names>MT</given-names></name>, <name name-style="western"><surname>Posa</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Gunaga</surname><given-names>S</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>The GENESIS Project (GENeralized Early Sepsis Intervention Strategies): A Multicenter Quality Improvement Collaborative</article-title>. <source>J Intensive Care Med</source> <volume>28</volume>: <fpage>355</fpage>–<lpage>368</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1003871-Salomao1"><label>5</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Salomao</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Brunialti</surname><given-names>MK</given-names></name>, <name name-style="western"><surname>Rapozo</surname><given-names>MM</given-names></name>, <name name-style="western"><surname>Baggio-Zappia</surname><given-names>GL</given-names></name>, <name name-style="western"><surname>Galanos</surname><given-names>C</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Bacterial sensing, cell signaling, and modulation of the immune response during sepsis</article-title>. <source>Shock</source> <volume>38</volume>: <fpage>227</fpage>–<lpage>242</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1003871-Hashimoto1"><label>6</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hashimoto</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Tawaratsumida</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Kariya</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Kiyohara</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Suda</surname><given-names>Y</given-names></name>, <etal>et al</etal>. (<year>2006</year>) <article-title>Not lipoteichoic acid but lipoproteins appear to be the dominant immunobiologically active compounds in <italic>Staphylococcus aureus</italic></article-title>. <source>J Immunol</source> <volume>177</volume>: <fpage>3162</fpage>–<lpage>3169</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1003871-BubeckWardenburg1"><label>7</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bubeck Wardenburg</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Williams</surname><given-names>WA</given-names></name>, <name name-style="western"><surname>Missiakas</surname><given-names>D</given-names></name> (<year>2006</year>) <article-title>Host defenses against <italic>Staphylococcus aureus</italic> infection require recognition of bacterial lipoproteins</article-title>. <source>Proc Natl Acad Sci U S A</source> <volume>103</volume>: <fpage>13831</fpage>–<lpage>13836</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1003871-DeKimpe1"><label>8</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>De Kimpe</surname><given-names>SJ</given-names></name>, <name name-style="western"><surname>Kengatharan</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Thiemermann</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Vane</surname><given-names>JR</given-names></name> (<year>1995</year>) <article-title>The cell wall components peptidoglycan and lipoteichoic acid from <italic>Staphylococcus aureus</italic> act in synergy to cause shock and multiple organ failure</article-title>. <source>Proc Natl Acad Sci U S A</source> <volume>92</volume>: <fpage>10359</fpage>–<lpage>10363</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1003871-SalgadoPabon1"><label>9</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Salgado-Pabon</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Breshears</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Spaulding</surname><given-names>AR</given-names></name>, <name name-style="western"><surname>Merriman</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Stach</surname><given-names>CS</given-names></name>, <etal>et al</etal>. (<year>2013</year>) <article-title>Superantigens are critical for <italic>Staphylococcus aureus</italic> Infective endocarditis, sepsis, and acute kidney injury</article-title>. <source>MBio</source> <volume>4</volume>: <fpage>e00494</fpage>–<lpage>13</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1003871-Yoong1"><label>10</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yoong</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Torres</surname><given-names>VJ</given-names></name> (<year>2013</year>) <article-title>The effects of <italic>Staphylococcus aureus</italic> leukotoxins on the host: cell lysis and beyond</article-title>. <source>Curr Opin Microbiol</source> <volume>16</volume>: <fpage>63</fpage>–<lpage>69</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1003871-Wang1"><label>11</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wang</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Braughton</surname><given-names>KR</given-names></name>, <name name-style="western"><surname>Kretschmer</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Bach</surname><given-names>T-HL</given-names></name>, <name name-style="western"><surname>Queck</surname><given-names>SY</given-names></name>, <etal>et al</etal>. (<year>2007</year>) <article-title>Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA</article-title>. <source>Nature Medicine</source> <volume>13</volume>: <fpage>1510</fpage>–<lpage>1514</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1003871-Berube1"><label>12</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Berube</surname><given-names>BJ</given-names></name>, <name name-style="western"><surname>Bubeck Wardenburg</surname><given-names>J</given-names></name> (<year>2013</year>) <article-title><italic>Staphylococcus aureus</italic> alpha-Toxin: Nearly a Century of Intrigue</article-title>. <source>Toxins (Basel)</source> <volume>5</volume>: <fpage>1140</fpage>–<lpage>1166</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1003871-Li1"><label>13</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Li</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Diep</surname><given-names>BA</given-names></name>, <name name-style="western"><surname>Villaruz</surname><given-names>AE</given-names></name>, <name name-style="western"><surname>Braughton</surname><given-names>KR</given-names></name>, <name name-style="western"><surname>Jiang</surname><given-names>X</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>Evolution of virulence in epidemic community-associated methicillin-resistant <italic>Staphylococcus aureus</italic></article-title>. <source>Proc Natl Acad Sci U S A</source> <volume>106</volume>: <fpage>5883</fpage>–<lpage>5888</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1003871-Chua1"><label>14</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chua</surname><given-names>KY</given-names></name>, <name name-style="western"><surname>Seemann</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Harrison</surname><given-names>PF</given-names></name>, <name name-style="western"><surname>Monagle</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Korman</surname><given-names>TM</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>The dominant Australian community-acquired methicillin-resistant <italic>Staphylococcus aureus</italic> clone ST93-IV [2B] is highly virulent and genetically distinct</article-title>. <source>PLoS One</source> <volume>6</volume>: <fpage>e25887</fpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0025887" xlink:type="simple">10.1371/journal.pone.0025887</ext-link></comment></mixed-citation>
</ref>
<ref id="ppat.1003871-DeLeo1"><label>15</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>DeLeo</surname><given-names>FR</given-names></name>, <name name-style="western"><surname>Kennedy</surname><given-names>AD</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Bubeck Wardenburg</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Kobayashi</surname><given-names>SD</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>Molecular differentiation of historic phage-type 80/81 and contemporary epidemic <italic>Staphylococcus aureus</italic></article-title>. <source>Proc Natl Acad Sci U S A</source> <volume>108</volume>: <fpage>18091</fpage>–<lpage>18096</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1003871-Malachowa1"><label>16</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Malachowa</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Kobayashi</surname><given-names>SD</given-names></name>, <name name-style="western"><surname>Braughton</surname><given-names>KR</given-names></name>, <name name-style="western"><surname>Whitney</surname><given-names>AR</given-names></name>, <name name-style="western"><surname>Parnell</surname><given-names>MJ</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title><italic>Staphylococcus aureus</italic> leukotoxin GH promotes inflammation</article-title>. <source>J Infect Dis</source> <volume>206</volume>: <fpage>1185</fpage>–<lpage>1193</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1003871-Powers1"><label>17</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Powers</surname><given-names>ME</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>HK</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Bubeck Wardenburg</surname><given-names>J</given-names></name> (<year>2012</year>) <article-title>ADAM10 mediates vascular injury induced by <italic>Staphylococcus aureus</italic> alpha-hemolysin</article-title>. <source>J Infect Dis</source> <volume>206</volume>: <fpage>352</fpage>–<lpage>356</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1003871-Alonzo1"><label>18</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Alonzo</surname><given-names>F</given-names><suffix>3rd</suffix></name>, <name name-style="western"><surname>Benson</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Novick</surname><given-names>RP</given-names></name>, <name name-style="western"><surname>Shopsin</surname><given-names>B</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title><italic>Staphylococcus aureus</italic> leucocidin ED contributes to systemic infection by targeting neutrophils and promoting bacterial growth in vivo</article-title>. <source>Mol Microbiol</source> <volume>83</volume>: <fpage>423</fpage>–<lpage>435</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1003871-Dumont1"><label>19</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Dumont</surname><given-names>AL</given-names></name>, <name name-style="western"><surname>Nygaard</surname><given-names>TK</given-names></name>, <name name-style="western"><surname>Watkins</surname><given-names>RL</given-names></name>, <name name-style="western"><surname>Smith</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Kozhaya</surname><given-names>L</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>Characterization of a new cytotoxin that contributes to <italic>Staphylococcus aureus</italic> pathogenesis</article-title>. <source>Mol Microbiol</source> <volume>79</volume>: <fpage>814</fpage>–<lpage>825</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1003871-Nizet1"><label>20</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Nizet</surname><given-names>V</given-names></name> (<year>2007</year>) <article-title>Understanding how leading bacterial pathogens subvert innate immunity to reveal novel therapeutic targets</article-title>. <source>J Allergy Clin Immunol</source> <volume>120</volume>: <fpage>13</fpage>–<lpage>22</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1003871-deHaas1"><label>21</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>de Haas</surname><given-names>CJ</given-names></name>, <name name-style="western"><surname>Veldkamp</surname><given-names>KE</given-names></name>, <name name-style="western"><surname>Peschel</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Weerkamp</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Van Wamel</surname><given-names>WJ</given-names></name>, <etal>et al</etal>. (<year>2004</year>) <article-title>Chemotaxis inhibitory protein of <italic>Staphylococcus aureus</italic>, a bacterial antiinflammatory agent</article-title>. <source>J Exp Med</source> <volume>199</volume>: <fpage>687</fpage>–<lpage>695</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1003871-Postma1"><label>22</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Postma</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Poppelier</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>van Galen</surname><given-names>JC</given-names></name>, <name name-style="western"><surname>Prossnitz</surname><given-names>ER</given-names></name>, <name name-style="western"><surname>van Strijp</surname><given-names>JA</given-names></name>, <etal>et al</etal>. (<year>2004</year>) <article-title>Chemotaxis inhibitory protein of <italic>Staphylococcus aureus</italic> binds specifically to the C5a and formylated peptide receptor</article-title>. <source>J Immunol</source> <volume>172</volume>: <fpage>6994</fpage>–<lpage>7001</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1003871-Rooijakkers1"><label>23</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rooijakkers</surname><given-names>SH</given-names></name>, <name name-style="western"><surname>Ruyken</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Roos</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Daha</surname><given-names>MR</given-names></name>, <name name-style="western"><surname>Presanis</surname><given-names>JS</given-names></name>, <etal>et al</etal>. (<year>2005</year>) <article-title>Immune evasion by a staphylococcal complement inhibitor that acts on C3 convertases</article-title>. <source>Nat Immunol</source> <volume>6</volume>: <fpage>920</fpage>–<lpage>927</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1003871-Rooijakkers2"><label>24</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rooijakkers</surname><given-names>SH</given-names></name>, <name name-style="western"><surname>Ruyken</surname><given-names>M</given-names></name>, <name name-style="western"><surname>van Roon</surname><given-names>J</given-names></name>, <name name-style="western"><surname>van Kessel</surname><given-names>KP</given-names></name>, <name name-style="western"><surname>van Strijp</surname><given-names>JA</given-names></name>, <etal>et al</etal>. (<year>2006</year>) <article-title>Early expression of SCIN and CHIPS drives instant immune evasion by <italic>Staphylococcus aureus</italic></article-title>. <source>Cell Microbiol</source> <volume>8</volume>: <fpage>1282</fpage>–<lpage>1293</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1003871-Lindmark1"><label>25</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lindmark</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Thoren-Tolling</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Sjoquist</surname><given-names>J</given-names></name> (<year>1983</year>) <article-title>Binding of immunoglobulins to protein A and immunoglobulin levels in mammalian sera</article-title>. <source>J Immunol Methods</source> <volume>62</volume>: <fpage>1</fpage>–<lpage>13</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1003871-Goodyear1"><label>26</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Goodyear</surname><given-names>CS</given-names></name>, <name name-style="western"><surname>Silverman</surname><given-names>GJ</given-names></name> (<year>2004</year>) <article-title>Staphylococcal toxin induced preferential and prolonged in vivo deletion of innate-like B lymphocytes</article-title>. <source>Proc Natl Acad Sci U S A</source> <volume>101</volume>: <fpage>11392</fpage>–<lpage>11397</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1003871-Cheng1"><label>27</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cheng</surname><given-names>AG</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>HK</given-names></name>, <name name-style="western"><surname>Burts</surname><given-names>ML</given-names></name>, <name name-style="western"><surname>Krausz</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Schneewind</surname><given-names>O</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>Genetic requirements for <italic>Staphylococcus aureus</italic> abscess formation and persistence in host tissues</article-title>. <source>Faseb J</source> <volume>23</volume>: <fpage>3393</fpage>–<lpage>3404</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1003871-Kim1"><label>28</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kim</surname><given-names>HK</given-names></name>, <name name-style="western"><surname>Cheng</surname><given-names>AG</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>HY</given-names></name>, <name name-style="western"><surname>Missiakas</surname><given-names>DM</given-names></name>, <name name-style="western"><surname>Schneewind</surname><given-names>O</given-names></name> (<year>2010</year>) <article-title>Nontoxigenic protein A vaccine for methicillin-resistant <italic>Staphylococcus aureus</italic> infections in mice</article-title>. <source>J Exp Med</source> <volume>207</volume>: <fpage>1863</fpage>–<lpage>1870</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1003871-Palmqvist1"><label>29</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Palmqvist</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Foster</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Tarkowski</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Josefsson</surname><given-names>E</given-names></name> (<year>2002</year>) <article-title>Protein A is a virulence factor in <italic>Staphylococcus aureus</italic> arthritis and septic death</article-title>. <source>Microb Pathog</source> <volume>33</volume>: <fpage>239</fpage>–<lpage>249</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1003871-ReyesRobles1"><label>30</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Reyes-Robles</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Alonzo</surname><given-names>F</given-names><suffix>3rd</suffix></name>, <name name-style="western"><surname>Kozhaya</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Lacy</surname><given-names>DB</given-names></name>, <name name-style="western"><surname>Unutmaz</surname><given-names>D</given-names></name>, <etal>et al</etal>. (<year>2013</year>) <article-title><italic>Staphylococcus aureus</italic> Leukotoxin ED Targets the Chemokine Receptors CXCR1 and CXCR2 to Kill Leukocytes and Promote Infection</article-title>. <source>Cell Host Microbe</source> <volume>14</volume>: <fpage>453</fpage>–<lpage>459</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1003871-Panizzi1"><label>31</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Panizzi</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Friedrich</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Fuentes-Prior</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Richter</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Bock</surname><given-names>PE</given-names></name>, <etal>et al</etal>. (<year>2006</year>) <article-title>Fibrinogen substrate recognition by staphylocoagulase (pro)thrombin complexes</article-title>. <source>J Biol Chem</source> <volume>281</volume>: <fpage>1179</fpage>–<lpage>1187</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1003871-Bjerketorp1"><label>32</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bjerketorp</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Jacobsson</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Frykberg</surname><given-names>L</given-names></name> (<year>2004</year>) <article-title>The von Willebrand factor-binding protein (vWbp) of <italic>Staphylococcus aureus</italic> is a coagulase</article-title>. <source>FEMS Microbiol Lett</source> <volume>234</volume>: <fpage>309</fpage>–<lpage>314</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1003871-McAdow1"><label>33</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>McAdow</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>HK</given-names></name>, <name name-style="western"><surname>Dedent</surname><given-names>AC</given-names></name>, <name name-style="western"><surname>Hendrickx</surname><given-names>AP</given-names></name>, <name name-style="western"><surname>Schneewind</surname><given-names>O</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>Preventing <italic>Staphylococcus aureus</italic> sepsis through the inhibition of its agglutination in blood</article-title>. <source>PLoS Pathog</source> <volume>7</volume>: <fpage>e1002307</fpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.ppat.1002307" xlink:type="simple">10.1371/journal.ppat.1002307</ext-link></comment></mixed-citation>
</ref>
<ref id="ppat.1003871-Schouten1"><label>34</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Schouten</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Wiersinga</surname><given-names>WJ</given-names></name>, <name name-style="western"><surname>Levi</surname><given-names>M</given-names></name>, <name name-style="western"><surname>van der Poll</surname><given-names>T</given-names></name> (<year>2008</year>) <article-title>Inflammation, endothelium, and coagulation in sepsis</article-title>. <source>J Leukoc Biol</source> <volume>83</volume>: <fpage>536</fpage>–<lpage>545</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1003871-Engelmann1"><label>35</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Engelmann</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Massberg</surname><given-names>S</given-names></name> (<year>2013</year>) <article-title>Thrombosis as an intravascular effector of innate immunity</article-title>. <source>Nat Rev Immunol</source> <volume>13</volume>: <fpage>34</fpage>–<lpage>45</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1003871-Wong1"><label>36</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wong</surname><given-names>CH</given-names></name>, <name name-style="western"><surname>Jenne</surname><given-names>CN</given-names></name>, <name name-style="western"><surname>Petri</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Chrobok</surname><given-names>NL</given-names></name>, <name name-style="western"><surname>Kubes</surname><given-names>P</given-names></name> (<year>2013</year>) <article-title>Nucleation of platelets with blood-borne pathogens on Kupffer cells precedes other innate immunity and contributes to bacterial clearance</article-title>. <source>Nat Immunol</source> <volume>14</volume>: <fpage>785</fpage>–<lpage>792</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1003871-Bhakdi1"><label>37</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bhakdi</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Muhly</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Mannhardt</surname><given-names>U</given-names></name>, <name name-style="western"><surname>Hugo</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Klapettek</surname><given-names>K</given-names></name>, <etal>et al</etal>. (<year>1988</year>) <article-title>Staphylococcal alpha toxin promotes blood coagulation via attack on human platelets</article-title>. <source>J Exp Med</source> <volume>168</volume>: <fpage>527</fpage>–<lpage>542</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1003871-Edwards1"><label>38</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Edwards</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Potts</surname><given-names>JR</given-names></name>, <name name-style="western"><surname>Josefsson</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Massey</surname><given-names>RC</given-names></name> (<year>2010</year>) <article-title><italic>Staphylococcus aureus</italic> host cell invasion and virulence in sepsis is facilitated by the multiple repeats within FnBPA</article-title>. <source>PLoS Pathog</source> <volume>6</volume>: <fpage>e1000964</fpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.ppat.1000964" xlink:type="simple">10.1371/journal.ppat.1000964</ext-link></comment></mixed-citation>
</ref>
<ref id="ppat.1003871-Carnes1"><label>39</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Carnes</surname><given-names>EC</given-names></name>, <name name-style="western"><surname>Lopez</surname><given-names>DM</given-names></name>, <name name-style="western"><surname>Donegan</surname><given-names>NP</given-names></name>, <name name-style="western"><surname>Cheung</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Gresham</surname><given-names>H</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>Confinement-induced quorum sensing of individual <italic>Staphylococcus aureus</italic> bacteria</article-title>. <source>Nat Chem Biol</source> <volume>6</volume>: <fpage>41</fpage>–<lpage>45</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1003871-Bagnoli1"><label>40</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bagnoli</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Bertholet</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Grandi</surname><given-names>G</given-names></name> (<year>2012</year>) <article-title>Inferring reasons for the failure of <italic>Staphylococcus aureus</italic> vaccines in clinical trials</article-title>. <source>Front Cell Infect Microbiol</source> <volume>2</volume>: <fpage>16</fpage>.</mixed-citation>
</ref>
<ref id="ppat.1003871-Lemichez1"><label>41</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lemichez</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Lecuit</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Nassif</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Bourdoulous</surname><given-names>S</given-names></name> (<year>2010</year>) <article-title>Breaking the wall: targeting of the endothelium by pathogenic bacteria</article-title>. <source>Nat Rev Microbiol</source> <volume>8</volume>: <fpage>93</fpage>–<lpage>104</lpage>.</mixed-citation>
</ref>
</ref-list></back>
</article>